期刊文献+

Biodegradation behavior of magnesium and ZK60 alloy in artificial urine and rat models 被引量:8

原文传递
导出
摘要 In this work, the biodegradable and histocompatibility properties of pure Mg and ZK60 alloy wereinvestigated as new temporary implants for urinary applications. The corrosion mechanism in artificialurine was proposed using electrochemical impedance spectroscopy and potentiodynamic polarizationtests. The corrosion potential of pure magnesium and ZK60 alloy were -1820 and -1561 mV, respectively,and the corrosion current densities were 59.66 ± 6.41 and 41.94 ± 0.53 μA cm^-2, respectively. Thein vitro degradation rates for pure Mg and ZK60 alloy in artificial urine were 0.382 and 1.023 mm/y,respectively, determined from immersion tests. The ZK60 alloy degraded faster than the pure Mg in bothartificial urine and in rat bladders (the implants of both samples are ø 3 mm × 5 mm). Histocompatibilityevaluations showed good histocompatibility for the pure Mg and ZK60 alloy during the 3 weeks postimplantationin rat bladders, and no harm was observed in the bladder, liver and kidney tissues. Theresults provide key information on the degradation properties and corrosion mechanism of pure Mg andZK60 alloy in the urinary system.
出处 《Bioactive Materials》 SCIE 2017年第2期53-62,共10页 生物活性材料(英文)
基金 This work is supported by the National Natural Science Foundation of China(NSFC,No.51431002&No.51601222) China Postdoctoral Science Foundation funded project(2016M591040) the Air Force General Hospital Grant(kz2015054).
  • 相关文献

参考文献1

二级参考文献156

  • 1G.L. Song, S.Z. Song, Adv. Eng. Mater. 9 (2007) 298-302. 被引量:1
  • 2F. Witte, V. Kaese, H. Haferkamp, E. Switzer, A. Meyer-Lindenberg, C.J. Wirth, H. Windhagen, Biomaterials 26 (2005) 3. 被引量:1
  • 3J.C. Gao, S. Wu, L.Y. Qiao, Y. Wang, Trans. Nonferrous Met. Soc. China 18 (2008) 588-592. 被引量:1
  • 4B. Heublein, R. Rohde, V. Kaese, M. Niemeyer, W. Hartung, A. Haverich, Heart 89 (2003) 651-656. 被引量:1
  • 5C.D. Mario, H. Griffiths, O. Goktekin, J. Interv. Cardiol. 17 (2004) 391-395. 被引量:1
  • 6P. Peeters, M. Bosiers, J. Verbist, K. Deloose, B. Heublein, J. Endovascular Ther. 12 (2005) 1-5. 被引量:1
  • 7R. Erbel, C. Di Mario, J. Bartunek, J. Bonnier, B. de Bruyne, F.R. Eberli, P. Erne, M. Haude, B. Heublein, M. Horriga. 被引量:1
  • 8R. Waksman, EuroIntervention 5 (2009) FI03-FI08. 被引量:1
  • 9S.S.A. El-Rahman, Pharmacol. Res. 47 (2003) 189-194. 被引量:1
  • 10Y Nakamura, Y Tsumura, Y. Tonogai, T. Shibata, Y Ito, Toxicol. Sci. 37 (1997) 106-116. 被引量:1

共引文献62

同被引文献44

引证文献8

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部